J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimitrov, T.
Right arrow Articles by Shehab, E.-D. M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimitrov, T.
Right arrow Articles by Shehab, E.-D. M. R.
Agricola
Right arrow Articles by Dimitrov, T.
Right arrow Articles by Shehab, E.-D. M. R.
J Med Microbiol 56 (2007), 277-279; DOI: 10.1099/jmm.0.46773-0
© 2007 Society for General Microbiology
ISSN 1473-5644

Case Report

Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin

Tzonyo Dimitrov1, Edet E. Udo2, Osama Albaksami3, Abdul A. Kilani4 and El-Din M. R. Shehab4

1 Department of Medical Laboratories, Microbiology Section, Infectious Diseases Hospital, PO Box 4710, Safat 13048, Kuwait

2 Department of Microbiology, Faculty of Medicine, Kuwait University, PO Box 24923, Safat 13110, Kuwait

3 Department of Pediatrics, Infectious Diseases Hospital, PO Box 4710, Safat 13048, Kuwait

4 Department of Medicine, Infectious Diseases Hospital, PO Box 4710, Safat 13048, Kuwait

Correspondence
Tzonyo Dimitrov
dimitrov_varn90{at}hotmail.com

Received 11 June 2006
Accepted 6 October 2006

This report describes a case of ciprofloxacin treatment failure in a patient with enteric fever caused by Salmonella enterica serotype Paratyphi A. The organism was isolated from a blood culture from a patient who was treated with oral ciprofloxacin (500 mg every 12 h) for 13 days. The organism showed reduced susceptibility to ciprofloxacin (MIC 0.75 µg ml–1) and was resistant to nalidixic acid. The patient was then placed on intravenous ceftriaxone (1 g every 12 h) and responded within 3 days. The patient was discharged after 9 days on ceftriaxone with no relapse on follow-up. This case adds to the increasing incidence of treatment failures with ciprofloxacin in typhoid fever caused by typhoid salmonellae with reduced susceptibility to ciprofloxacin. It also highlights the inadequacy of current laboratory methods for fluoroquinolone susceptibility testing in adequately predicting in vivo activity of ciprofloxacin against typhoid salmonellae and supports calls for new guidelines for fluoroquinolone susceptibility testing of these organisms.

Abbreviations: CLSI, Clinical and Laboratory Standards Institute.




This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
S. Cui, J. Li, Z. Sun, C. Hu, S. Jin, F. Li, Y. Guo, L. Ran, and Y. Ma
Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China
J. Antimicrob. Chemother., November 4, 2008; (2008) dkn452v1.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2007 Society for General Microbiology.